Yalan Tu

703 total citations
17 papers, 589 citations indexed

About

Yalan Tu is a scholar working on Biomedical Engineering, Biomaterials and Organic Chemistry. According to data from OpenAlex, Yalan Tu has authored 17 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 9 papers in Biomaterials and 5 papers in Organic Chemistry. Recurrent topics in Yalan Tu's work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Click Chemistry and Applications (5 papers). Yalan Tu is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Click Chemistry and Applications (5 papers). Yalan Tu collaborates with scholars based in China and Russia. Yalan Tu's co-authors include Youyong Yuan, Yansong Dong, Kewei Wang, Xuan Xiao, Jun Wang, Qingyu Zong, Cong‐Fei Xu, Xinqing Jiang, Ruimeng Yang and Yao Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and Biomaterials.

In The Last Decade

Yalan Tu

16 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yalan Tu China	12	364	210	174	126	121	17	589
Qingyu Zong China	15	345 0.9×	182 0.9×	187 1.1×	82 0.7×	132 1.1×	25	529
Tingxizi Liang China	17	392 1.1×	364 1.7×	258 1.5×	85 0.7×	232 1.9×	24	866
Xuliang Guo China	12	342 0.9×	184 0.9×	178 1.0×	114 0.9×	178 1.5×	18	640
Faiza Javaid United Kingdom	6	234 0.6×	233 1.1×	223 1.3×	94 0.7×	99 0.8×	7	574
Shiqi Hu China	11	272 0.7×	236 1.1×	261 1.5×	65 0.5×	112 0.9×	19	601
Die Jia China	13	377 1.0×	170 0.8×	310 1.8×	59 0.5×	126 1.0×	14	595
Yuxun Ding China	16	431 1.2×	273 1.3×	379 2.2×	61 0.5×	177 1.5×	26	831
Krzysztof Sztandera Poland	9	307 0.8×	183 0.9×	218 1.3×	61 0.5×	228 1.9×	12	655
Keke Chai China	12	235 0.6×	141 0.7×	84 0.5×	53 0.4×	139 1.1×	21	437
Caixia Yang China	12	401 1.1×	172 0.8×	142 0.8×	209 1.7×	217 1.8×	18	734

Countries citing papers authored by Yalan Tu

Since Specialization

Citations

This map shows the geographic impact of Yalan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Tu more than expected).

Fields of papers citing papers by Yalan Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yalan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Tu. The network helps show where Yalan Tu may publish in the future.

Co-authorship network of co-authors of Yalan Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yalan Tu. A scholar is included among the top collaborators of Yalan Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalan Tu. Yalan Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

An, Qi, et al.. (2025). New strategies to enhance the efficiency and precision of drug discovery. Frontiers in Pharmacology. 16. 1550158–1550158. 6 indexed citations

2.

Zong, Qingyu, et al.. (2025). A tumor heterogeneity-independent antigen-responsive nanocarrier enabled by bioorthogonal pre-targeting and click-activated self-immolative polymer. Biomaterials. 319. 123200–123200. 1 indexed citations

3.

Dong, Yansong, Yalan Tu, Ye Liu, et al.. (2023). Perivascular nanocarrier aggregation as a drug reservoir augments tumor drug delivery and treatment efficacy. Nano Today. 53. 102004–102004. 3 indexed citations

4.

Dong, Yansong, Ye Liu, Yalan Tu, Youyong Yuan, & Jun Wang. (2023). AIEgens Cross‐linked Iron Oxide Nanoparticles Synchronously Amplify Bimodal Imaging Signals in Situ by Tumor Acidity‐Mediated Click Reaction. Angewandte Chemie. 135(52).

5.

Dong, Yansong, Ye Liu, Yalan Tu, Youyong Yuan, & Jun Wang. (2023). AIEgens Cross‐linked Iron Oxide Nanoparticles Synchronously Amplify Bimodal Imaging Signals in Situ by Tumor Acidity‐Mediated Click Reaction. Angewandte Chemie International Edition. 62(52). e202310975–e202310975. 17 indexed citations

6.

Tu, Yalan, Xuan Xiao, Yansong Dong, et al.. (2022). Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy. Biomaterials. 289. 121795–121795. 54 indexed citations

7.

Wang, Kewei, Xuan Xiao, Ye Liu, et al.. (2022). Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy. Biomaterials. 289. 121803–121803. 25 indexed citations

8.

Zhao, Yangyang, Yansong Dong, Shuhan Yang, et al.. (2022). Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy. ACS Central Science. 8(5). 603–614. 63 indexed citations

9.

Xiao, Xuan, Kewei Wang, Qingyu Zong, et al.. (2021). Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal. Biomaterials. 270. 120649–120649. 63 indexed citations

10.

Tu, Yalan, et al.. (2021). Dual drug delivery system with flexible and controllable drug ratios for synergistic chemotherapy. Science China Chemistry. 64(6). 1020–1030. 10 indexed citations

11.

Liu, Ye, Maolin Jiang, Yalan Tu, et al.. (2021). Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy. Biomaterials. 278. 121136–121136. 18 indexed citations

12.

Tu, Yalan, Shi‐Wei Luo, Xuan Xiao, et al.. (2021). Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy. Nano Letters. 21(5). 2216–2223. 57 indexed citations

13.

Dong, Yansong, Yalan Tu, Shi‐Wei Luo, et al.. (2021). Bioorthogonal Pretargeting Strategy for Anchoring Activatable Photosensitizers on Plasma Membranes for Effective Photodynamic Therapy. ACS Applied Materials & Interfaces. 13(12). 14004–14014. 27 indexed citations

14.

Tu, Yalan, Yansong Dong, Kewei Wang, et al.. (2020). Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration. Biomaterials. 259. 120298–120298. 48 indexed citations

15.

Dong, Yansong, Yalan Tu, Kewei Wang, et al.. (2020). A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry. Angewandte Chemie. 132(18). 7235–7239. 30 indexed citations

16.

Wang, Kewei, Yalan Tu, Yao Wang, et al.. (2020). Size-Switchable Nanoparticles with Self-Destructive and Tumor Penetration Characteristics for Site-Specific Phototherapy of Cancer. ACS Applied Materials & Interfaces. 12(6). 6933–6943. 51 indexed citations

17.

Dong, Yansong, Yalan Tu, Kewei Wang, et al.. (2020). A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry. Angewandte Chemie International Edition. 59(18). 7168–7172. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact